
Freezing Fort Knox: Mesenteric Carcinoid Cryoablation
Author(s) -
Erik Soule,
Arya Bagherpour,
Jerry Matteo
Publication year - 2017
Publication title -
gastrointestinal tumors
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2296-3766
pISSN - 2296-3774
DOI - 10.1159/000479794
Subject(s) - medicine , cryoablation , malignancy , percutaneous , neuroendocrine tumors , metastasis , radiology , surgery , pathology , cancer , ablation
Neuroendocrine malignancy is indolent, yet relentless in its propensity to metastasize to the liver, where it may cause bizarre paraneoplastic syndromes. The pathophysiologic mechanism behind this predilection for hepatic metastasis is twofold: the portal venous system drains the most likely primary sites for neuroendocrine tumors, and the relatively immunosuppressed environment within the hepatic parenchyma is permissive for tumor growth. The standard of care for patients with metastatic neuroendocrine tumor is surgical resection of at least 90% of the tumor burden.